Austrianova
20 Biopolis Way #05-518 Centros
138668
Tel: 65-6779-3867
Fax: 65-6774-5569
Website: http://austrianova.com/
Email: sec@austrianova.com
24 articles about Austrianova
-
Austrianova Secures Significant Investment from Real Tech Fund
7/7/2021
Real Tech Fund is a venture capital firm that invests specifically in innovative deep-technology startups mainly in Japan and Southeast Asia. Austrianova was assisted in this transaction by Square Associates.
-
Austrianova Secures $100 Million USD Investment Commitment from GEM as Company Seeks to Go Public
4/23/2021
Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is pleased to announce that it has signed an Agreement with GEM Global Yield LLC SCS ("GEM"), the Luxembourg based private alternative investment group, to provide Austrianova with a share subscription facility of up to $100 million USD for a 36-month term following a public listing.
-
Complete protection of probiotics from destruction by stomach acid using Bac-in-a-Box technology
11/30/2020
Austrianova announced today that a key publication on the ability of its patented technology, Bac-in-a-Box, to completely protect probiotics from acidic conditions found in the stomach has been published in the well respected journal “Microbial Cell Factories”.
-
Cells for Cells and Austrianova announce publication on novel method to produce stem cell exosomes
5/22/2020
Austrianova and Cells for Cells have just jointly published a ground breaking, peer reviewed, scientific publication on a novel, cost and time-saving method to generate extra-cellular vesicles (EVs) from encapsulated Mesenchymal Stem Cells (MSCs).
-
PharmaCyte Biotech Successfully Completes Final Manufacturing Run of Clinical Trial Product
11/18/2019
The capsules, which are fully filled with genetically modified live cells, were immediately put into PharmaCyte’s clinical trial syringes and then frozen.
-
PharmaCyte Biotech Announces Encapsulation of Live Cells for Clinical Trial in Pancreatic Cancer
1/15/2019
PharmaCyte Biotech (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced PharmaCyte’s partner, Austrianova, has successfully encapsulated the live cells used in PharmaCyte’s therapy for its planned clinical trial in patients with locally advanced, non-metastatic, inoperable pancreatic cancer (LAPC).
-
PharmaCyte Biotech Successfully Completes Final Pre-Production Run of Pancreatic Cancer Product
9/18/2018
Austrianova, has successfully performed an additional pre-production “engineering run” using the Cell-in-a-Box® encapsulated cells that will be used, in combination with low doses of the cancer prodrug ifosfamide, for the treatment of locally advanced, non-metastatic, inoperable pancreatic cancer
-
PharmaCyte’s Clinical Trial Cells Arrive Safely at Austrianova’s Encapsulation Facility
4/5/2018
The vials of cells from PharmaCyte’s Master Cell Bank (MCB) that were shipped by Eurofins Lancaster Laboratories (Eurofins) to Austrianova’s encapsulation facility in Thailand have arrived safely.
-
PharmaCyte Ships Clinical Trial Cells to Austrianova for Encapsulation
4/2/2018
The cells from the MCB will be encapsulated and then tested by Austrianova after encapsulation
-
Austrianova Facility Commissioned For GMP Manufacturing
4/25/2016
-
Austrianova Expands Its Business Area
1/25/2016
-
PharmaCyte Biotech's Partner Austrianova Opens New Facilities in Singapore
1/29/2015
-
Nuvilex's Partner Austrianova Successfully Completes First Live Cell Encapsulation In New Facility
12/18/2014
-
Austrianova press release: Austrianova Officially Opens New Lab And GMP facility In Thailand
12/4/2014
-
Nuvilex's Partner, Austrianova, Publishes Scientific Review Article Emphasizing Use Of Cell-In-A-Box® For Treatment Of Diabetes
9/22/2014
-
Nuvilex's Partner, Austrianova, Receives Prestigious Emerging Enterprises 2014 Best Innovation Award In Singapore
9/8/2014
-
Austrianova Release: Human Clinical Trials Confirm Safety And Efficacy Of Encapsulated Cell Treatment For Pancreatic Cancer
8/15/2014
-
Nuvilex And Austrianova Announce Results Of Clinical Trial In Dogs With Mammary Tumors Treated With Cell-In-A-Box® Plus Cyclophosphamide
7/17/2014
-
Austrianova's Thai Subsidiary Signs Agreement With Thailand Science Park For Lab And Office Facilities Near Bangkok
3/7/2014
-
Nuvilex Partner Austrianova Establishes Regional Headquarters And Research And Development Facility At Thailand Science Park For Cell-In-A-Box™ Live-Cell Encapsulation
3/6/2014